Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal

Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal

Ayala Pharmaceuticals, a Nasdaq-listed clinical-stage oncology company, has entered into a merger deal with New Jersey-based biotech company Advaxis. Based in Delaware, Ayala Pharmaceuticals is engaged in developing small molecule therapeutics for aggressive cancers and rare tumors. On the other hand, Advaxis is focused on developing immunotherapies based on a technology that makes use of […]

Provident Financial Services and Lakeland Bancorp to merge in $1.3bn deal

Provident Financial Services and Lakeland Bancorp to merge in $1.3bn deal

Publicly-listed New Jersey-based bank holding companies Provident Financial Services and Lakeland Bancorp have agreed to an all-stock merger deal worth around $1.3 billion. While Provident Financial Services is the parent company of Provident Bank, Lakeland Bancorp is the holding company for Lakeland Bank. The enlarged bank holding company will have over $25 billion in assets […]

Dr. Reddy’s Labs, Slayback sign licensing deal for Brimonidine Tartrate

Dr. Reddy’s Labs, Slayback sign licensing deal for Brimonidine Tartrate

Dr. Reddy’s Laboratories said that it has signed a licensing deal with New Jersey-based Slayback Pharma for acquiring rights in the latter’s Brimonidine Tartrate Ophthalmic Solution 0.025%. Brimonidine Tartrate Ophthalmic Solution 0.025% is the private label equivalent of Lumify in the US. Lumify, which is an over-the-counter (OTC) eyedrop, can be used for easing the […]

Halozyme Therapeutics to acquire specialty pharma company Antares Pharma for $960m

Halozyme Therapeutics to acquire specialty pharma company Antares Pharma for $960m

Halozyme Therapeutics, a California-based publicly-listed biotech company, has agreed to acquire New Jersey-based specialty pharma company Antares Pharma for around $960 million with an objective to create a specialty product and drug delivery major. As per the terms of the deal, shareholders of the publicly-listed Antares Pharma will be paid $5.6 per share in cash. […]

Persistent Systems wraps up $90.5m acquisition of Data Glove

Persistent Systems wraps up $90.5m acquisition of Data Glove

Persistent Systems has wrapped up the previously announced $90.5 million acquisition of Data Glove, a business transformation services provider based in New Jersey. The deal was announced last month by Persistent Systems. Persistent Systems said that the required customary closing conditions regarding the asset acquisition of Data Glove IT Solutions Private Limited, India, asset acquisitions […]

Persistent Systems to acquire New Jersey-based Data Glove in $90.5m deal

Persistent Systems to acquire New Jersey-based Data Glove in $90.5m deal

Persistent Systems, an Indian technology services company, has agreed to acquire Data Glove, a New Jersey-based provider of business transformation services, in a deal worth up to $90.5 million. The consideration includes a maximum earnout of $34.88 million to be paid over the next two years, which will be contingent on meeting certain performance thresholds. […]

Quidel to acquire in vitro diagnostics company Ortho Clinical Diagnostics

Quidel to acquire in vitro diagnostics company Ortho Clinical Diagnostics

Quidel Corporation, a manufacturer of diagnostic healthcare products, has agreed to acquire Ortho Clinical Diagnostics, a New Jersey-based in vitro diagnostics company, in a deal worth about $6 billion. As per the terms of the deal, announced on 23 December 2021, the California-based Quidel will pay $24.68 per share to the shareholders of Ortho Clinical […]